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Introduction
Antimicrobial resistance poses a serious security threat to 
global health. In Thailand alone, such resistance is estimated 
to have caused 38 000 deaths and an economic loss of 1.2 bil-
lion United States dollars (US$) in 2010.1 Subsequent global 
attention and national concern pushed the Thai government 
to take action against antimicrobial resistance.
The increased prevalence and global spread of drug-
resistant microorganisms are alarming.2 Antimicrobial resis-
tance is recognized as a key security threat to global health. 
By 2050 – if effective interventions against antimicrobial 
resistance are not made – 10 million deaths and an economic 
loss of US$ 100 trillion may occur annually as the result of 
such resistance.3 In 2015, the Sixty-eighth World Health As-
sembly adopted a Global action plan for antimicrobial resistance 
and called on each Member State to develop and implement a 
corresponding context-specific national plan.4 Discussion of 
antimicrobial resistance at the United Nations General As-
sembly in September 2016 led to a political declaration that 
endorsed the implementation of the global action plan using 
a One Health approach.5,6
Thailand has previously addressed antimicrobial resis-
tance with fragmented approaches. For example, antimicrobial 
resistance formed a small component of the National drug 
development strategy (2012–2016) and the National strategic 
plan on emerging infectious disease (2013–2016). Although 
several relevant working groups were established, no platform 
for coordination existed and only very limited policy guidance. 
None of the working groups established national indicators, 
systems for monitoring and evaluation or targets. Fragmenta-
tion and the lack of both coordination and concerted efforts 
hampered progress.
Local setting
In Thailand, although the widespread availability of antibiot-
ics from private pharmacies leads to frequent self-medication 
in households, no systems exist either to monitor the human 
consumption of antibiotics or to assess the general public’s 
knowledge and perceptions of – or attitudes towards –antibi-
otics and antimicrobial resistance. A national system for the 
surveillance of antimicrobial resistance in humans was initi-
ated by the ministry of public health’s department of medical 
sciences in 19987 but this system covered only 92 (9%) of the 
country’s 1027 hospitals by 2017. Furthermore, the use of the 
antimicrobial resistance profiles and prevalence determined at 
these 92 sentinel hospitals to guide clinical decision-making 
by pharmacists or physicians appears to be uncommon.
Thailand’s department of livestock development and 
food and drug administration have conducted some small-
scale monitoring of antimicrobial resistance in livestock, and 
Problem In Thailand, antimicrobial resistance has formed a small component of national drug policies and strategies on emerging infectious 
diseases. However, poor coordination and a lack of national goals and monitoring and evaluation platforms have reduced the effectiveness 
of the corresponding national actions.
Approach On the basis of local evidence and with the strong participation of relevant stakeholders, the first national strategic plan on 
antimicrobial resistance has been developed in Thailand.
Local setting Before the development of the plan, ineffective coordination meant that antimicrobial resistance profiles produced at 
sentinel hospitals were not used effectively for clinical decision-making. There was no integrated system for the surveillance of antimicrobial 
resistance, no system for monitoring consumption of antimicrobial drugs by humans, livestock and pets and little public awareness of 
antimicrobial resistance.
Relevant changes In August 2016, the Thai government endorsed a national strategic plan on antimicrobial resistance that comprised six 
strategic actions and five targets. A national steering committee guides the plan’s implementation and a module to assess the prevalence 
of household antibiotic use and antimicrobial resistance awareness has been embedded into the biennial national health survey. A national 
system for the surveillance of antimicrobial consumption has also been initiated.
Lessons learnt Strong political commitment, national ownership and adequate multisectoral institutional capacities will be essential 
for the effective implementation of the national plan. A robust monitoring and evaluation platform now contributes to evidence-based 
interventions. An integrated system for the surveillance of antimicrobial resistance still needs to be established.
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some universities have undertaken some 
research on this topic. However, nobody 
has conducted a systematic evaluation of 
the emergence or prevalence of antimi-
crobial resistance in livestock.
The surveillance of antimicrobial 
resistance in – and consumption of an-
timicrobial drugs by – humans, livestock 
and pets is key to assessing consump-
tion trends, evaluating the outcomes 
of interventions and creating national 
benchmarks for use in international 
comparisons. However, despite the high 
estimates of mean global antibiotic con-
sumption in humans – e.g. more than 
20 standard units per capita8 – and in 
chickens and pigs – e.g. more than 250 
kg per 10 km2 of land used to rear such 
animals9 – there are, as yet, no national 
policy decisions to support the develop-
ment of a comprehensive surveillance 
system in Thailand.
Approach
In Thailand, the development of a Na-
tional strategic plan on antimicrobial 
resistance at the end of 2015 was per-
haps the most important step towards 
addressing the fragmentation in the 
investigation of antimicrobial resistance 
and the lack of associated systematic 
interventions. The many stakeholders 
involved in this development included 
those working in the agriculture, ani-
mal health and human health sectors, 
civil society organizations, the Food and 
Agricultural Organization of the United 
Nations (FAO) and the World Health 
Organization (WHO). The implementa-
tion of the plan was facilitated by the cre-
ation of a national coordinating commit-
tee for antimicrobial resistance, which 
had the support of a cross-ministerial 
joint secretariat. The plan was based on 
both the relevant local evidence that 
was available – e.g. on antimicrobial re-
sistance in hospitals, livestock and food 
products and on resistance-attributable 
mortality and economic losses – and 
on the relevant information available 
from other countries – e.g. on policies 
and practices that curb antimicrobial 
consumption and systems for the sur-
veillance of antimicrobial resistance.
In December 2015, in response 
to the need for evidence-based policy 
formulation and multisectoral actions, 
antimicrobial resistance was included in 
the agenda of Thailand’s eighth national 
health assembly.10 Representatives from 
academia, civil society and government 
intensively reviewed the Draft national 
strategic plan on antimicrobial resistance 
and officially adopted a resolution on 
the collaborative and comprehensive 
management of antimicrobial resistance 
in Thailand. To ensure that the final plan 
was based on broad stakeholder involve-
ment, the draft plan was discussed by 
several hundred stakeholders over three 
public hearings. At the first of these 
hearings, the members of the antimicro-
bial resistance coordinating committee 
introduced the proposed plan’s key fea-
tures. The plan was drafted in detail at 
the second hearing and finalized at the 
third hearing. Antimicrobial resistance 
is the focus of one of six programmes 
included in the Thai government’s coun-
try cooperation strategy for 2017–2021.
Relevant changes
After a series of meticulous engagement 
processes – in particular for identifying 
potential problems and strategic direc-
tions – the Thai government finally 
endorsed the strategic plan in August 
2016 (Box 1). A national steering com-
mittee, chaired by the deputy prime 
minister, is charged with overseeing and 
coordinating the plan’s implementation 
and eliminating the fragmentation that 
hampered previous investigations of 
antimicrobial resistance in Thailand. It 
is hoped that the stakeholders’ involve-
ment in the plan’s development will lead 
to a genuine sense of stakeholder own-
ership and the plan’s long-term efficacy 
and sustainability. It is also hoped that 
the trust-based relationships that exist 
among the steering committee’s long-
serving technocrats who facilitated the 
plan’s development, i.e. government of-
ficials in the ministries of health and ag-
riculture – will strengthen and then also 
support the plan’s effective long-term 
implementation. However, it may be 
difficult to sustain policy commitment 
because of the typically high turnover of 
policy-makers.
The strategic plan is designed to 
act as a framework that assigns differ-
ent responsibilities to different institu-
tions and sectors – according to their 
mandates – with the ultimate aim of 
achieving set national goals and targets 
(Box 1).
To strengthen the monitoring and 
evaluation of antimicrobial resistance 
and develop the surveillance of antimi-
crobial consumption, the International 
Health Policy Program of Thailand’s 
ministry of public health has convened 
a series of intensive consultations. These 
consultations cover multiple stakeholder 
groups: faculties of pharmacy and vet-
erinary medicine, FAO, several hospi-
tals, Thailand’s department of livestock 
development, food and drug administra-
tion and national laboratory and WHO. 
The examination of key data sets on 
antimicrobial sales – i.e. the results of 
mandatory reporting by importers and 
manufacturers to the food and drug 
administration – indicates that it may 
be feasible to apply similar approaches 
in Thailand to those used in Europe by 
the European surveillance of antimi-
crobial consumption network11 and the 
European surveillance of veterinary 
Box 1. Actions and targets of the national strategic plan on antimicrobial resistance, 
Thailand, 2016
Actions
• Strengthen surveillance of resistance, using One Health approach
• Regulate antimicrobial distribution
• Prevent infection in humans while controlling and optimizing use of antimicrobial drugs 
• Prevent infection in livestock and pets while controlling and optimizing use of antimicrobial 
drugs
• Increase public knowledge and awareness of antimicrobial resistance
Targets to be achieved by 2021
• 50% reduction in morbidity attributable to antimicrobial resistance
• 20% reduction in mean consumption of antimicrobial drugs by humans
• 30% reduction in mean consumption of antimicrobial drugs by livestock and pets
• 20% increase in the proportion of the population shown to have a pre-defined basic level 
of knowledge and awareness of antimicrobial resistance
• Capacity of the national plan’s implementation to have reached level 4 – as measured by 
the World Health Organization’s Joint External Evaluation tool for the 2005 International 
Health Regulations
Bull World Health Organ 2017;95:599–603| doi: http://dx.doi.org/10.2471/BLT.16.179648 601
Lessons from the field
Responses to antimicrobial resistance in ThailandViroj Tangcharoensathien et al.
antimicrobial consumption project.12 
An assessment of total antimicrobial 
consumption by humans, livestock and 
pets should provide useful data for 
monitoring the progress of the strategic 
plan’s implementation.13 The magnitude, 
pattern and types of antibiotic use in 
pets will be assessed because people 
commonly use antibiotics created for 
human consumption to treat their pets. 
Assessment of the wide use of antibiotics 
to treat greening diseases in citrus trees 
is also underway.
Adequate monitoring of the preva-
lence of antimicrobial resistance in 
Thailand will require both the existing 
system for monitoring humans to be 
strengthened and a whole new system 
for monitoring livestock and pets to be 
established. Ideally, given the emergence 
of resistant foodborne infections in hu-
mans, disease surveillance for humans 
and livestock needs to be integrated.6,14
A new module on antimicrobial 
resistance, based on a slight adaptation 
of the format used in the Euro-Barom-
eter 445 survey of such resistance,15 
has been embedded into Thailand’s 
biennial national health and welfare 
surveys, i.e. nationally representative 
household surveys conducted by the 
national statistical office. The Interna-
tional Health Policy Program’s long-
term institutional relationship with the 
national statistical office facilitated the 
inclusion of the new module. The mod-
ule will be used to assess the prevalence 
of self-use of antibiotics, knowledge 
and awareness of antimicrobial resis-
tance and sources of information on 
antimicrobial resistance. Ideally, all 
decision-making on antimicrobial use 
– by clinicians, policy-makers, the gen-
eral public and veterinarians – needs to 
be evidence-based.
Lessons learnt
Strong political commitment, national 
ownership and increased institutional 
capacities contributed to the develop-
ment of the strategic plan (Box 2). 
Looking ahead, the plan’s effective 
implementation will require the re-
maining challenges to be overcome, 
continued political commitments and a 
strong technical secretariat. The process 
of developing the strategic plan placed 
a high priority on engagement and 
ownership by key actors, particularly 
the technocrats who were involved in 
much of the plan’s contents and who 
will, probably, be much involved in the 
plan’s implementation. Given the high 
turnover of policy-makers, it may be dif-
ficult to sustain policy commitment. ■
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抗菌素耐药性 : 从全球议程到泰国国家战略计划 
问题 在泰国 , 抗菌素耐药性已成为针对新发现传染疾









 نم  ًلايئض  اًصرنع  دنليات  في  تابوركيلما  ةمواقم  تلكش  ةلكشلما
 ةيدعلما  ضارملأا  نأشب  ةينطولا  ةيودلأا  تايجيتاترساو  تاسايس
 فادهلأا  بايغو  قيسنتلا  فعض  ىدأ  دقف  ،كلذ  عمو  .ةئشانلا
 تاءارجلإا  ةيلاعف  صيلقت  لىإ  مييقتلاو  دصرلا  تاصنمو  ةينطولا
.ةلباقلما ةينطولا
 باحصأ نم ةيوق  ةكراشمبو ةيلحلما  ةلدلأا  لىإ  اًدانتسا  بولسلأا
 نأشب ةينطو ةيجيتاترسا ةطخ لوأ عضو مت دقف ،ينينعلما ةحلصلما
.دنليات في تابوركيلما ةمواقم
 نأ ينعي لاعفلا يرغ قيسنتلا ناك ،ةطلخا عضو لبق ةيلحلما عقاولما
 نكت  لم  ةيرفلخا  تايفشتسلما  في  ةتجانلا  تابوركيلما  ةمواقم  طمانأ
 ماظن كانه نكي لمو .يريسرلا رارقلا ذاتخلا لاعف لكشب مدختسُت
 كلاهتسا  دصرل  ماظن  لاو  ،تابوركيلما  ةمواقم  ةبقارلم  لماكتم
 تاناويلحاو ةيشالماو شربلا لبق نم تابوركيملل ةمواقلما  يرقاقعلا
.تابوركيلما ةمواقمب ماعلا يعولا فعض لىإ ةفاضلإاب ،ةفيللأا
 ةيجيتاترسا  ةطخ  ةيدنلياتلا  ةموكلحا  ترقأ  ةلصلا  تاذ  تاّيغتلا
 تاءارـجإ  ةتس  مضت  يتلاو  تابوركيلما  ةمواقم  نأشب  ةينطو
 ماع نم سطسغأ/بآ رهش في كلذو فادهأ ةسخمو ةيجيتاترسا
 مت  دقو ،ةطلخا  ذيفنتب  ةينعم  ةينطو ةيهيجوت  ةنلج دجوتو .2016
 ينب ةيويلحا تاداضلما مادختسا راشتنا ىدم مييقتل ةدحو ينمضت
 ينطولا يحصلا حسلما في تابوركيلما ةمواقمب يعولاو تلائاعلا
 كلاهتسا ةبقارلم ينطو ماظنب لمعلا أدب ماك .ينتنس لك ىرُي يذلا
.تابوركيلما ةمواقم
 ةيلوؤسلماو  يوقلا  سيايسلا  مازتللاا  نوكيس  ةدافتسلما  سوردلا
 اًيساسأ اًرمأ تاعاطقلا ةددعتم ةيفاكلا ةيسسؤلما تاردقلاو ةينطولا
 دصرلل  ةيوق  ةصنم  نلآا  مهاستو  .ةينطولا  ةطخلل  لاعفلا  ذيفنتلل
 ءاشنإ  ينعتي  لازي  لاو  .ةلدلأا  لىع  ةمئاقلا  تلاخدتلا  في  مييقتلاو
.تابوركيلما ةمواقم ةبقارلم لماكتم ماظن
Box 2. Summary of main lessons learnt
• Strong political commitment, national ownership and adequate multisectoral institutional 
capacities will be essential for the effective implementation of Thailand’s first national 
strategic plan on antimicrobial resistance.
• A robust monitoring and evaluation platform now contributes to evidence-based 
interventions.
• An integrated system for the surveillance of antimicrobial resistance in humans, livestock 
and pets still needs to be established.
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相关变化 2016 年 8 月 , 泰国政府批准了一项抗菌素耐
药性国家战略计划 , 其中包括六项战略行动和五个目









Résistance aux antimicrobiens: de l’agenda mondial au plan stratégique national - Thaïlande
Problème En Thaïlande, le problème de résistance aux antimicrobiens 
était partiellement pris en compte dans les stratégies et politiques 
nationales liées à la consommation de médicaments et destinées à 
lutter contre les maladies infectieuses émergentes. Mais des problèmes 
de coordination et l’absence d’objectifs nationaux et de plateformes 
de surveillance et d’évaluation limitaient l’efficacité de ces initiatives 
nationales.
Approche À partir des données factuelles disponibles sur la situation 
locale et grâce à une importante participation des parties prenantes 
concernées, la Thaïlande a élaboré son premier plan stratégique national 
sur la résistance aux antimicrobiens.
Environnement local Avant la conception de ce plan, une coordination 
inefficace faisait que les profils de résistance aux antimicrobiens produits 
dans les hôpitaux sentinelles n’étaient pas efficacement utilisés dans 
la prise de décisions cliniques. Il n’existait aucun système intégré de 
surveillance de la résistance aux antimicrobiens, aucun système de 
suivi de la consommation d’antimicrobiens par les humains, le bétail 
et les animaux domestiques, et la population était peu sensibilisée au 
problème de résistance aux antimicrobiens.
Changements significatifs En août 2016, le gouvernement thaïlandais 
a validé un plan stratégique national sur la résistance aux antimicrobiens, 
comprenant six actions stratégiques et cinq objectifs. Un comité de 
pilotage national a été constitué pour guider la mise en œuvre du 
plan, et un module destiné à évaluer la prévalence de l’utilisation des 
antibiotiques dans les ménages et la sensibilisation à la résistance 
aux antimicrobiens a été intégré dans l’enquête nationale sur la santé 
réalisée tous les deux ans. Un système national pour la surveillance de 
la consommation d’antimicrobiens a également été lancé.
Leçons tirées Un engagement politique fort, une mobilisation nationale 
et des capacités institutionnelles multisectorielles appropriées seront 
essentiels pour une mise en œuvre efficace du plan national. Une 
solide plateforme d’évaluation et de surveillance contribue désormais 
à fonder les interventions sur des données factuelles. Mais un système 
intégré pour la surveillance de la résistance aux antimicrobiens doit 
encore être créé.
Резюме
Устойчивость возбудителей к противомикробным препаратам: от глобальной повестки дня до 
национального стратегического плана, Таиланд
Проблема В Таиланде проблема устойчивости возбудителей к 
противомикробным препаратам стала одним из второстепенных 
направлений национальной политики и стратегии в отношении 
применения лекарственных препаратов при вновь возникающих 
инфекционных заболеваниях. Однако слабая координация и 
отсутствие национальных целей и платформ мониторинга и 
оценки снизили эффективность соответствующих национальных 
мероприятий.
Подход С учетом местных данных и при активном участии 
соответствующих заинтересованных сторон в Таиланде был 
разработан первый национальный стратегический план 
по решению проблемы с устойчивостью возбудителей к 
противомикробным препаратам.
Местные условия До разработки плана неэффективная 
координация означала, что профили устойчивости возбудителей 
к противомикробным препаратам, составленные в дозорных 
больницах, неэффективно использовались при принятии 
клинических решений. Отсутствовала единая система для 
наблюдения за устойчивостью возбудителей к противомикробным 
препаратам, а также система мониторинга применения 
противомикробных препаратов у людей, сельскохозяйственных 
и домашних животных, и информированность общественности 
об устойчивости возбудителей к противомикробным препаратам 
была недостаточной.
О с у щ е с т в л е н н ы е  п е р е м е н ы  В  а в г у с те  2 0 1 6  го д а 
Правительство Таиланда одобрило национальный стратегический 
план по решению проблемы устойчивости возбудителей к 
противомикробным препаратам, который включал шесть 
стратегических мероприятий и пять целей. Национальный 
управляющий комитет руководит реализацией плана, и в 
двухгодичный обзор общественного здравоохранения включен 
встроенный модуль оценки распространенности использования 
антибиотиков в домашних условиях и осведомленности 
общественности о микробной устойчивости. Также была 
введена национальная система наблюдения за применением 
антимикробных препаратов.
Выводы Для эффективной реализации национального плана 
крайне важны решительная политическая приверженность, 
национальная ответственность и наличие соответствующего 
многосекторального институционального потенциала. 
Надежная платформа мониторинга и оценки в настоящее время 
вносит свой вклад в научно обоснованные вмешательства. 
Комплексную систему надзора за устойчивостью возбудителей 
к противомикробным препаратам все еще предстоит создать. 
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Resumen
Resistencia a los antimicrobianos: de un programa mundial a un plan estratégico nacional, Tailandia
Situación En Tailandia, la resistencia a los antimicrobianos ha formado 
un pequeño componente de las políticas y estrategias de medicamentos 
nacionales sobre las enfermedades infecciosas emergentes. No 
obstante, la escasa coordinación y la ausencia de objetivos nacionales 
y plataformas de control y evaluación han reducido la efectividad de 
las medidas nacionales correspondientes.
Enfoque Sobre la base de las pruebas locales y con la gran participación 
de partes interesadas relevantes, se ha desarrollado en Tailandia el primer 
plan estratégico nacional sobre la resistencia a los antimicrobianos.
Marco regional Antes de desarrollar el plan, la mala coordinación 
provocó que los perfiles de resistencia a los antimicrobianos producidos 
en los hospitales centinela no se utilizasen de forma adecuada para la 
toma de decisiones clínicas. No existía un sistema integrado para la 
vigilancia de la resistencia a los antimicrobianos, ni un sistema para el 
control del consumo de medicamentos antimicrobianos por parte de 
humanos, ganado y mascotas, ni apenas concienciación pública sobre 
la resistencia a los antimicrobianos.
Cambios importantes En agosto de 2016, el gobierno tailandés aprobó 
un plan estratégico nacional sobre la resistencia a los antimicrobianos 
que estaba formado por seis medidas estratégicas y cinco objetivos. Un 
comité directivo nacional dirige la implementación del plan y un módulo 
para evaluar la prevalencia del uso doméstico de antibióticos y se ha 
integrado la concienciación sobre la resistencia a los antimicrobianos 
en la encuesta nacional bienal sobre salud. También se ha iniciado un 
sistema nacional para la vigilancia del consumo de antimicrobianos.
Lecciones aprendidas Un fuerte compromiso político, una propiedad 
nacional y las capacidades institucionales multisectoriales adecuadas 
serán esenciales para la implementación eficaz del plan nacional. 
Ahora, una sólida plataforma de control y evaluación contribuye 
a las intervenciones basadas en pruebas. Sin embargo, aún debe 
establecerse un sistema integrado para la vigilancia de la resistencia a 
los antimicrobianos.
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